Felipe Olivieri is the latest fighter to fail a drug test under the UFC’s drug-testing program, which is overseen by theÂ United States Anti-Doping Agency.
Olivieri (14-5 MMA, 0-1 UFC) was submitted by Tony Martin (10-3 MMA, 2-3 UFC) at UFC on FOX 18, which took place Jan. 30 from Prudential Center in Newark, N.J. The bout was his debut in the promotion.
The UFC released a statement to announce the failure.
According to the statement, Olivier’s post-fight drug test was negative for banned substances. However, a pre-fight test from the lead-up to the bout was recently returned as testing positive.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Olivieri, as it relates to the UFC Anti-Doping Policy and future UFC participation, the statement read. Because Olivieri participated in a bout sanctioned by the New Jersey State Athletic Control Board after the sample in question was collected, USADA will work to ensure that the Board has the necessary information to determine the appropriate course of action under the Board’s rules.
741 tests have been conducted by USADA since the program’s launch, including 388 in 2016, according to the organization’s website.